IMV Inc IMVIF

RE:RE:RE:RE:RE:After ASCO

[Hideaway]

Answers are not easy to come by, but IMV is in a difficult situation for the next few weeks. There is little clinical news due between now and ASCO so support on this front is unlikely to occur. As I understand the US financing deal, Wells Fargo are not permitted to promote the stock for 90 days following the deal,and this takes us into early June, so no help on that front.
Traders know we are in this position so they are taking advantage ot this time to lower our Shareprice to buy lower and sell on the rebound. Shorting the stock would also do similar damage.
Further, the technicals are not in our favour,europe10 would be better informed than I to comment on this aspect.
I agree that more promotion would not hurt even if there was discussions of the many other application. Were we not in discussions with intrerested companies re  the RSV vaccine? What about the veteniarian side of things? We had explored numerous vaccine opportunities with various parties, what is progress? Unless partnerships could be announced for any of the above ,it probably would not help a lot, but any promotion would show the broader utility of our product.
I realize that they are concentrating on the upcoming clinical studies  as they should be,but it would be helpful to see some support for our stock on other fronts as well.
It is a difficult time for small retail investors and our options are limited. We can sell or hold. For now, I an staying in the hold camp and will not be suprised to see further SP deteriation in the absence of news.
GLTA